Tyra Biosciences Inc. (TYRA)
Tyra Biosciences Statistics
Share Statistics
Tyra Biosciences has 50.75M shares outstanding. The number of shares has increased by -3.29% in one year.
Shares Outstanding | 50.75M |
Shares Change (YoY) | -3.29% |
Shares Change (QoQ) | -4.01% |
Owned by Institutions (%) | 82.57% |
Shares Floating | 30.76M |
Failed to Deliver (FTD) Shares | 27.25K |
FTD / Avg. Volume | 9.23% |
Short Selling Information
The latest short interest is 2.77M, so 5.24% of the outstanding shares have been sold short.
Short Interest | 2.77M |
Short % of Shares Out | 5.24% |
Short % of Float | 9.02% |
Short Ratio (days to cover) | 10.8 |
Valuation Ratios
The PE ratio is -9.2 and the forward PE ratio is -7.78. Tyra Biosciences's PEG ratio is 1.35.
PE Ratio | -9.2 |
Forward PE | -7.78 |
PS Ratio | 0 |
Forward PS | 1.6 |
PB Ratio | 2.32 |
P/FCF Ratio | -11.29 |
PEG Ratio | 1.35 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Tyra Biosciences.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.81, with a Debt / Equity ratio of 0.02.
Current Ratio | 23.81 |
Quick Ratio | 23.81 |
Debt / Equity | 0.02 |
Debt / EBITDA | -0.06 |
Debt / FCF | -0.09 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-1.44M |
Employee Count | 60 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -50.68% in the last 52 weeks. The beta is 1.09, so Tyra Biosciences's price volatility has been higher than the market average.
Beta | 1.09 |
52-Week Price Change | -50.68% |
50-Day Moving Average | 12.09 |
200-Day Moving Average | 17.34 |
Relative Strength Index (RSI) | 25.08 |
Average Volume (20 Days) | 295.28K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -104.18M |
Net Income | -86.48M |
EBITDA | -104.18M |
EBIT | n/a |
Earnings Per Share (EPS) | -1.51 |
Balance Sheet
The company has 91.97M in cash and 6.22M in debt, giving a net cash position of 85.74M.
Cash & Cash Equivalents | 91.97M |
Total Debt | 6.22M |
Net Cash | 85.74M |
Retained Earnings | -251.31M |
Total Assets | 363.56M |
Working Capital | 332.87M |
Cash Flow
In the last 12 months, operating cash flow was -69.77M and capital expenditures -664K, giving a free cash flow of -70.44M.
Operating Cash Flow | -69.77M |
Capital Expenditures | -664K |
Free Cash Flow | -70.44M |
FCF Per Share | -1.23 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TYRA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for TYRA is $30.5, which is 251.4% higher than the current price. The consensus rating is "Buy".
Price Target | $30.5 |
Price Target Difference | 251.4% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Scores
Altman Z-Score | 12.2 |
Piotroski F-Score | 2 |